Delivery Order SPE2DB22D2211-SPE2DB23FNTK3

Award Date 7/17/23
Potential Completion Date 7/18/23
Potential Value $83
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $393,030 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. As part of DLA's medical supplies procurement program, this order calls for 30 grams of the topical immunosuppressant cream to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by the end of June 2023. No subcontractors or set aside designations were specified. This supports DLA's mission to provide medical logistics...
The Defense Logistics Agency awarded a $316 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. The single day order is for 100 grams of the topical immunosuppressant cream to support Defense Department health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $103,860 to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the topical immunosuppressant to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a one-day period of performance from September 21-22, 2023. The contract was awarded...
The Defense Logistics Agency awarded a $653 delivery order to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. The firm fixed price order is for 30 grams of the cream to be delivered from Amerisourcebergen's Conshohocken, Pennsylvania location to an unknown customer by July 31, 2023. Amerisourcebergen will fulfill the order as the prime contractor under an unspecified multiple award contract vehicle with DLA. No subcontractors or set aside designations were indicated. This order...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $221 to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. As the prime contractor, Amerisourcebergen will provide 30 grams of the prescribed topical cream to fulfill DLA requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. No subcontractors or set aside designations were indicated. This...
The Defense Logistics Agency awarded a $2,637.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. As the prime contractor, Amerisourcebergen will supply 100 grams of the prescribed topical cream to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility by August 4, 2023. The Defense Logistics Agency leverages contracts such as this to efficiently procure medical supplies in...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately six hundred sixteen dollars to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. As the prime contractor, Amerisourcebergen will deliver the topical immunosuppressant to an agency facility located in Conshohocken, Pennsylvania over a one-day period in late August 2023. The order was placed under an existing DLA contract vehicle but no additional details were provided. Amerisourcebergen, a...
The Defense Logistics Agency awarded a $174,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% Cream 30gm. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 18-21, 2023. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $244,960 delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. The firm fixed price order is for 30 grams of the topical cream to support Defense Department dermatological needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from June 21st to June 22nd, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
The Defense Logistics Agency awarded a $464 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. The cream will be delivered to a location in Conshohocken, Pennsylvania by July 17, 2023 to support Defense Logistics Agency programs. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will leverage its extensive distribution network to fulfill this order for a topical immunosuppressant medication on behalf of the Agency. No...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FNTK3
    Delivery Order

The Defense Logistics Agency awarded a $82,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. As part of DLA's medical supplies procurement program, this order supports delivery of 30 grams of the topical immunosuppressant cream to a location in Conshohocken, Pennsylvania by July 18, 2023. Amerisourcebergen will serve as the prime contractor, drawing from its extensive distribution network to fulfill this short-term requirement for a specialty pharmaceutical on behalf of DOD customers. No subcontractors or set aside designations were identified. The award builds upon DLA's strategic relationships with medical product suppliers to ensure critical items remain available to military treatment facilities and beneficiaries as needed.

Generated 12/23/23, 1:01 PM